The WHO recommendations reflect the currently circulating viruses in the southern hemisphere, and the change of both A(H3N2) and B virus components is based on the available surveillance and virus characterisation data.
The results from three animal species all point in the same direction: it seems possible to develop influenza vaccine candidates with at least broader cross-protection and possibly universal ones using different technologies.
This new publication from Novartis in collaboration with public health and academic researchers in Finland and the US adds to the evidence-base on how narcolepsy might have been triggered in genetically susceptible individuals.
On the occasion of the tenth anniversary of European Immunization Week, ECDC is releasing a new complement of data, tools, blogs and updates to support public health authorities in their work against vaccine preventable diseases.
The World Health Organization (WHO) has agreed on the recommended composition of the trivalent influenza vaccine for the northern hemisphere 2015-2016 influenza season.
ECDC welcomes the Council Conclusions, as of 1 December 2014, and will continue to support the EU and its Member States in responding to the invitations for action described in these and previous Council conclusions.
In November 2014, the Pharmacovigilance Centre of Netherlands (Lareb) provided an updated overview of Dutch cases of narcolepsy reported to have a link to Pandemrix.
The World Health Organization (WHO) ha.s agreed on the recommended composition of the trivalent influenza vaccine for the southern hemisphere winter 2015 influenza season.